Skip to main content
. 2020 Jul 23;11:1096. doi: 10.3389/fphar.2020.01096

Figure 2.

Figure 2

(A) The proportion of publications published in Pubmed (https://www.ncbi.nlm.nih.gov/pubmed) by years about “anti-inflammatory,” “mucolytic,” and “antibiotic” in combination with “cystic fibrosis” compared to the total number of publications in CF. (B) The proportion of publications published in Pubmed by years about “anti-inflammatory,” “mucolytic,” and “antibiotic” in CF. (C) The proportion of publications published in Pubmed by years about “mucus,” “infection,” and “inflammation” in combination with “cystic fibrosis” compared to the total number of publications in CF. (D) The proportion of publications published in Pubmed by years about “mucus,” “infection,” and “inflammation” in CF.